Cargando…
A Biochemical/Biophysical Assay Dyad for HTS-Compatible Triaging of Inhibitors of the HIV-1 Nef/Hck SH3 Interaction
The current treatment regimens for HIV include over 20 anti-retrovirals. However, adverse drug effects and the emergence of drug resistance necessitates the continued improvement of the existing drug classes as well as the development of novel drugs that target as yet therapeutically unexploited vir...
Autores principales: | Breuer, Sebastian, Espinola, Sheryll, Morelli, Xavier, Torbett, Bruce E, Arold, Stefan T, Engels, Ingo H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854662/ https://www.ncbi.nlm.nih.gov/pubmed/24396731 http://dx.doi.org/10.2174/2213988501307010016 |
Ejemplares similares
-
HIV-1 Nef interaction influences the ATP-binding site of the Src-family kinase, Hck
por: Pene-Dumitrescu, Teodora, et al.
Publicado: (2012) -
HIV-1 Infection of T Cells and Macrophages Are Differentially Modulated by Virion-Associated Hck: A Nef-Dependent Phenomenon
por: Cornall, Alyssa, et al.
Publicado: (2013) -
HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1
por: O’Leary, Debra A., et al.
Publicado: (2010) -
The SH3 regulatory domain of the hematopoietic cell kinase Hck binds ELMO via its polyproline motif
por: Awad, Rida, et al.
Publicado: (2015) -
HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels
por: Priceputu, Elena, et al.
Publicado: (2021)